ATRA vs HAS · rev $128.9M vs P/E 25, rev $4.75B
Atara Biotherapeutics Inc (ATRA) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
ATRA currently screens at market cap $87.1M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the ATRA and HAS stock pages for the full models.
Not investment advice.